Welcome to our dedicated page for GOLDFIELD news (Ticker: GV), a resource for investors and traders seeking the latest updates and insights on GOLDFIELD stock.
Visionary Holdings Inc. reports developments tied to its healthcare, biotechnology, and medical-aesthetics focus, including commercialization activity for anti-aging and regenerative wellness products. Company updates have covered V-series anti-aging products, RAMU-related products, Premier Regenerative Complex-President Super Injection, distribution arrangements, channel development, and healthcare service collaborations in markets including China.
Recurring news also includes Nasdaq listing-compliance matters for GV common shares, periodic reporting status, listing-fee notices, shareholder voting matters, governance actions, capital-structure disclosures, and operating and financial results.
The Goldfield Corporation (NYSE American: GV) reported record revenue of $181 million in 2019, up 31% from $138 million in 2018, driven by increased electrical construction activities and real estate development. Net income rose to $6.7 million from $5 million, with EPS improving from $0.20 to $0.27. Entering 2020, the company maintained a robust backlog of $473 million, more than doubling year-over-year, and reported improved margins. Despite the COVID-19 pandemic, operations remained stable, and the company anticipates continued growth supported by infrastructure projects and a strong customer base.
The Goldfield Corporation (NYSE American: GV) reported its financial results for Q1 2020, highlighting a 127.2% increase in total backlog to $473 million compared to the previous year. Electrical construction revenue rose 4.1% to $43.1 million, driven by master service agreements in the Texas-Southwest region. However, consolidated revenue decreased 5.6% to $44.8 million due to lower real estate development activity, with net income falling 16.8% to $1.5 million. The company remains committed to employee safety amid COVID-19, citing no adverse effects on operations thus far.
Summary not available.